Literature DB >> 20824221

PURLs: Another option for patients with liver disease.

Umang A Sharma1.   

Abstract

Currently used to treat hepatic encephalopathy, rifaximin is effective at preventing this common complication of chronic liver disease, as well.

Entities:  

Year:  2010        PMID： 20824221      PMCID： PMC3183943     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  5 in total

Review 1.  Nonabsorbable disaccharides for hepatic encephalopathy.

Authors:  B Als-Nielsen; L L Gluud; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

2.  Rifaximin treatment in hepatic encephalopathy.

Authors:  Nathan M Bass; Kevin D Mullen; Arun Sanyal; Fred Poordad; Guy Neff; Carroll B Leevy; Samuel Sigal; Muhammad Y Sheikh; Kimberly Beavers; Todd Frederick; Lewis Teperman; Donald Hillebrand; Shirley Huang; Kunal Merchant; Audrey Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

Review 3.  Treatment of hepatic encephalopathy.

Authors:  S M Riordan; R Williams
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

4.  Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.

Authors:  Yong Han Paik; Kwan Sik Lee; Kwang Hyub Han; Kun Hoon Song; Myoung Hwan Kim; Byung Soo Moon; Sang Hoon Ahn; Se Joon Lee; Hyo Jin Park; Dong Ki Lee; Chae Yoon Chon; Sang In Lee; Young Myoung Moon
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

Review 5.  Rifaximin for the treatment of hepatic encephalopathy.

Authors:  Kenneth R Lawrence; Jacqueline A Klee
Journal:  Pharmacotherapy       Date:  2008-08       Impact factor: 4.705
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.